BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35150573)

  • 1. Approach to the Patient With Prader-Willi Syndrome.
    Höybye C; Tauber M
    J Clin Endocrinol Metab; 2022 May; 107(6):1698-1705. PubMed ID: 35150573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prader-Willi syndrome: an update on obesity and endocrine problems.
    Kim SJ; Cho SY; Jin DK
    Ann Pediatr Endocrinol Metab; 2021 Dec; 26(4):227-236. PubMed ID: 34991300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.
    Muscogiuri G; Formoso G; Pugliese G; Ruggeri RM; Scarano E; Colao A;
    Rev Endocr Metab Disord; 2019 Jun; 20(2):239-250. PubMed ID: 31065942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
    Muscogiuri G; Barrea L; Faggiano F; Maiorino MI; Parrillo M; Pugliese G; Ruggeri RM; Scarano E; Savastano S; Colao A;
    J Endocrinol Invest; 2021 Oct; 44(10):2057-2070. PubMed ID: 33891302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review.
    Napolitano L; Barone B; Morra S; Celentano G; La Rocca R; Capece M; Morgera V; Turco C; Caputo VF; Spena G; Romano L; De Luca L; Califano G; Collà Ruvolo C; Mangiapia F; Mirone V; Longo N; Creta M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
    Angulo MA; Butler MG; Cataletto ME
    J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity management in Prader-Willi syndrome: current perspectives.
    Crinò A; Fintini D; Bocchini S; Grugni G
    Diabetes Metab Syndr Obes; 2018; 11():579-593. PubMed ID: 30323638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
    Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
    J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
    McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
    J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome.
    Dykens EM; Roof E; Hunt-Hawkins H
    Orphanet J Rare Dis; 2024 Feb; 19(1):83. PubMed ID: 38395848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prader-Willi syndrome: Hormone therapies.
    Tauber M; Diene G
    Handb Clin Neurol; 2021; 181():351-367. PubMed ID: 34238470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in genetic mechanisms of hypothalamic dysfunction in Prader-Willi syndrome.
    Wang XY; Sun R; Gao YQ
    Yi Chuan; 2022 Oct; 44(10):899-912. PubMed ID: 36384726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prader-Willi syndrome: endocrine manifestations and management.
    Alves C; Franco RR
    Arch Endocrinol Metab; 2020; 64(3):223-234. PubMed ID: 32555988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine manifestations and management of Prader-Willi syndrome.
    Emerick JE; Vogt KS
    Int J Pediatr Endocrinol; 2013 Aug; 2013(1):14. PubMed ID: 23962041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
    Griggs JL; Sinnayah P; Mathai ML
    Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation.
    Madeo SF; Zagaroli L; Vandelli S; Calcaterra V; Crinò A; De Sanctis L; Faienza MF; Fintini D; Guazzarotti L; Licenziati MR; Mozzillo E; Pajno R; Scarano E; Street ME; Wasniewska M; Bocchini S; Bucolo C; Buganza R; Chiarito M; Corica D; Di Candia F; Francavilla R; Fratangeli N; Improda N; Morabito LA; Mozzato C; Rossi V; Schiavariello C; Farello G; Iughetti L; Salpietro V; Salvatoni A; Giordano M; Grugni G; Delvecchio M
    Front Endocrinol (Lausanne); 2024; 15():1382583. PubMed ID: 38737552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychiatric aspects of Prader-Willi syndrome – a review].
    Briegel W
    Z Kinder Jugendpsychiatr Psychother; 2018 May; 46(3):238-246. PubMed ID: 28613110
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.